Related Experiment Video
Updated: Sep 19, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Long-Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia
Taylor M Ward1, Jianing Xu2, Daniel B Hall2
1College of Pharmacy, University of Georgia, Athens, Georgia, USA.
This study analyzed long-acting injectable (LAI) antipsychotic use in children and adolescents. White patients had a lower discontinuation rate for LAI paliperidone palmitate compared to Black patients.
Area of Science:
- Pediatric Psychiatry
- Pharmacology
- Health Disparities
Background:
- Long-acting injectable (LAI) antipsychotics are crucial for managing schizophrenia and related disorders in pediatric populations.
- Understanding prescribing patterns and discontinuation rates of LAI antipsychotics is essential for optimizing treatment adherence and outcomes in children and adolescents.
- Investigating potential racial/ethnic disparities in LAI antipsychotic use and discontinuation is critical for ensuring equitable care.
Purpose of the Study:
- To analyze the prescribing and discontinuation rates of long-acting injectable (LAI) antipsychotics in child and adolescent populations.
- To determine if racial/ethnic differences exist in LAI antipsychotic prescribing and discontinuation rates.
Main Methods:
- Retrospective analysis of children and adolescents (2-17 years) diagnosed with schizophrenia or related disorders who received LAI antipsychotics between 2017-2021.
- Data sourced from the Merative MarketScan Multi-State Medicaid Database.
- Descriptive statistics, Kaplan-Meier survival curves, and Cox regression analyses were used to assess LAI antipsychotic use, discontinuation rates, and associated hazards.
Main Results:
- A total of 1277 patients were included; 94% received LAI second-generation antipsychotics, with paliperidone palmitate and aripiprazole formulations being most common.
- No significant difference in discontinuation rates was found between paliperidone and aripiprazole formulations when controlling for covariates.
- LAI paliperidone palmitate was associated with a 46% lower hazard of discontinuation in White patients compared to Black patients (HR=0.54, p=0.01).
Conclusions:
- This study provides insights into LAI antipsychotic prescribing and discontinuation in pediatric populations.
- Significant racial disparities were observed, with White patients exhibiting lower discontinuation rates for LAI paliperidone palmitate compared to Black patients.
- Further research is warranted to explore the reasons for discontinuation and the economic impact of LAI antipsychotics in this demographic.
More Related Videos
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Antipsychotic Drugs: Typical and Atypical Agents

